Veracity Network, Inc.

Our revolutionary solution is the only one that allows anyone anywhere to easily and quickly detect drugs that are counterfeited, contaminated, or sub-potent.

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Melbourne, FL, USA
  • Currency USD
  • Founded May 2011
  • Employees 6
  • Website veracitynetwork.us

Company Summary

Veracity Network provides innovative services for the detection of counterfeit pharmaceuticals. Counterfeit pharmaceuticals kill more than 700,000 people each year and counterfeiters generate $100B in profits. Our services allow any distributor or pharmacy to easily and non-intrusively perform a forensic verification of the drug while inside its packaging. Our service will detect counterfeits, contamination, and sub-potent drugs.

Team

  • Brian Mayo
    Founder and CEO

    Mr Mayo is a disruptive innovator with a number of industry firsts including the first data communication switch, Voice-over-IP, and virtual private networking (VPN). Mr. Mayo led the engineering and operations teams at Ardent Communications, which sold to Cisco Systems for over $200M and became the largest division at Cisco. Mr Mayo has the technical background to solve the most difficult challenges and business acumen to create new markets.

  • Dr. William Mayo
    Chairman of the Scientific Advisory Board

    Dr. William Mayo, professor emeritus at Rutgers, taught material science for over 25 years. Dr. Mayo holds a number of patents in new materials as well as novel material analysis techniques. Dr. Mayo also worked for industry stalwarts such as Bell Laboratories &TRW. Dr. Mayo earned his PhD at Rutgers, and performed undergraduate and graduate studies at Carnegie Mellon University with post-doctorate studies at prestigious Bell Laboratories.

  • Al Gapsch
    Chief Operations Officer

    Mr. Gapsch has over 35 years of professional technical management experience. Prior to Secure Pharma Chain, Mr. Gapsch was owner and managed an independent consulting group, Technical Solutions. Mr. Gapsch served as Vice President of Emerge Interactive from its inception through its initial public offering. Mr Gapsch led diverse applications for the US government, commercial maritime operations, banking industry, and animal diagnostics.

  • Charles Dozier
    Chief Scientist

    With over 35 years of experience with NASA and the Naval Research Laboratory, Mr. Dozier’s primary experience has been in x-ray diffraction and fluorescence. Mr. Dozier’s research included the use of x-ray technologies in weapons development, plasma physics, radiation hardened microelectronics, dosimetry and other material sciences. Mr. Dozier holds a Bachelor of Science and Master of Science degrees from Wake Forest University.

Advisors

  • Melissa Medlock
    Financial Controller
    Unconfirmed
    Dr. Charles McDonell
    Diagnostic Radiology
    Unconfirmed
    John Hollenbach
    Pharmaceuticals
    Unconfirmed
  • Dr. Nikitas Kleopoulos
    Indian River Medical Center
    Unconfirmed
    Dr. Mark Croft
    Materials Science Professor, Rutgers
    Unconfirmed
    Dr. Yoram Kalman
    Materials Science, University of Israel
    Unconfirmed
  • John Mellott
    Investment Banker, Bain Group
    Unconfirmed
    Robert Prindiville
    Director of Trilogy Global Advisors
    Unconfirmed
    James Ancey
    President at Rock Maple Services LLC
    Unconfirmed

Previous Investors

  • Department of Homeland Security
    Unconfirmed
    University of New Jersey, at Rutgers
    Unconfirmed
    Kimball International
    Unconfirmed
  • Thomas Cook
    President of ITT Grinnell Corporation
    Unconfirmed
    Jack Rogers
    CEO, Equifax
    Unconfirmed
    Jack Gruber
    Northwestern Mutual Financial Network
    Unconfirmed
  • Paul Becker
    Becker Investments, LLC
    Unconfirmed
    Robert Washburn
    Washburn Capital
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free